Hex N, Bartlett C, Wright D, Taylor M, Varley D. Estimating the Current and Future Costs of Type 1 and Type 2 Diabetes in the UK: Including direct health costs and indirect societal and productivity costs. Diabetic Medicine. 2010; 29: 855-62. https://jdrf.org.uk/wp-content/uploads/2015/10/Hex-and-Bartlett.pdf

Heintz E, Wirehn A, Peebo B, Rosenqvist U, Levin L. Prevalence and Healthcare Costs of Diabetic Retinopathy: A population-based register study in Sweden. Diabetologia. 2010; 53(10): 2147-54. http://link.springer.com/article/10.1007%2Fs00125-010-1836-3

Happich M, Reitberger U, Breitscheidel L, Ulbig M, Watkins J. The Economic Burden of Diabetic Retinopathy in Germany in 2002. Graefes Arch Clin Exp Ophthalmol. 2008; 246(1): 151-9. http://link.springer.com/article/10.1007%2Fs00417-007-0573-x

Gonzalez J, Walker J, Einarson T. Cost-of-Illness Study of Type 2 Diabetes Mellitus in Colombia. 2009; 26(1): 55-63. http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892009000700009

Barcelo A, Aedo C, Rajpathak S, Robles S. The Cost of Diabetes in Latin America and the Caribbean. Bulletin of the World Health Organization. 2003; 81: 19-27. http://www.who.int/bulletin/Barcelo0103.pdf